要求如下：為標(biāo)準(zhǔn)版產(chǎn)品備案資料，可以順利過審（廣東深圳）的資料，具體需求資料如下，缺一不可： 1、備案表 2、產(chǎn)品安全風(fēng)險分析報告 3、產(chǎn)品技術(shù)要求 4、產(chǎn)品檢驗報告 5、臨床評價資料 6 、產(chǎn)品說明書及最小銷售單元標(biāo)簽設(shè)計樣稿 7、生產(chǎn)制造信息 8、符合性聲明 9、工藝流程圖 10、主要生產(chǎn)和檢測設(shè)備清單 11、產(chǎn)品有效成分、有效成分占比及有效成分的作用   [更多]

標(biāo)題： 1、Comparative Pharmacokinetics of the New Oral Cephalosporins 2、Jiang X, Wang N, Zhang Z J, et al. Pharmacokinetics and comparative bioavailability of two terbinafine hydrochloride formulations after single-dose administration in Chinese healthy subjects.[J]. Arzneimittel-Forschung, 2008, 58(7):363-366. 3、Almeida S, Filipe A, Vallée F, et al. Comparative bioavailability of two formulations of terbinafine. Data from a cross-over, randomised, open-label bioequivalence study in healthy volunteers.[J]. Arzneimittel-Forschung, 2004, 54(11):757-62. 4、De-Oliveira C, Barrientos-Astigarraga R, De-Moraes M, et al. Terbinafine quantification in human plasma by high-performance liquid chromatography coupled to electrospray tandem mass spectrometry: application to a bioequivalence study.[J]. Therapeutic Drug Monitoring, 2001, 23(6):709. 5、Impact of moisture and magnesium stearate functionality on manufacturability of wet granulated metformin tablets 6、The?antipruritic?effect?of?5%?doxepin?cream?in?patients?with?eczematousdermatitis.?Doxepin?Study Group. 7、Photoisomerization of Ionic Liquid Ammonium Cinnamates: One-Pot Synthesis?Isolation of Z-Cinnamic Acids 8、[Pharmacokinetics and bioequivalence of atorvastatin calcium tablets in healthy male Chinese volunteers]. 9、Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein Lowering With Atorvastatin in Patients of South Asian Compared With European Origin: Insights From the Achieve Cholesterol Targets Fast With Atorvastatin Stratified Titration (ACTFAST) Study 10、Do the lipid responses to rosuvastatin and atorvastatin differ between Chinese and Caucasians? Comparison of the DISCOVERY-Hong Kong study with other DISCOVERY studies 備注：將符合的文獻PDF格式打包上傳   [更多]

地西泮注射液津藥和平（天津）最新說明書，要求通過一致性評價。要求：1.附件說明書。2.內(nèi)容完整且清晰。   [更多]

YBH，2018版   [更多]

求購戈舍瑞林植入劑復(fù)核標(biāo)準(zhǔn) 標(biāo)準(zhǔn)號JX20010474   [更多]

查詢一個藥品的銷售數(shù)據(jù)   [更多]

任務(wù)描述：根據(jù)文獻題目等相關(guān)信息，在網(wǎng)上下載準(zhǔn)確的文獻，每篇文獻1元。文獻數(shù)量有301篇，均是中文文獻，需要找三個威客來下載文獻，每人下載100篇。 要求：1.下載文件類型為PDF，內(nèi)容完整，文件名稱要包含文獻題目。 2.投稿的用戶自己有下載文獻的資源或途徑，我方不提供文獻庫的賬號等。 3.完成時間：2015年8月24日之前。4.一旦接受此項任務(wù)，不得中途退出。   [更多]

“7200元請人對藥品按ATC分類標(biāo)準(zhǔn)進行分類”，該任務(wù)中每組做得好的多獎勵一百元。獎勵領(lǐng)取在此交稿   [更多]

含中成藥蝎子為原料的制藥廠聯(lián)系方式及地址，采購具體細(xì)節(jié)。要求在5條。   [更多]

需求文獻： 1、DAWSON PA， KARPEN SJ． Bile acids reach out to the spinal cord： new insights to the pathogenesis of itch and analgesia in cholestatic liver disease ［J］． Hepatology， 2014， 59 （4）：1638－1641． 2、Kremer AE, van Dijk R, Leckie P, et al. Serum autotaxin is increased in pruirtus of cholestasis, but not of other oirgin, and responds to therapeutic interventions[J]. Hepatology, 2012(56): 1391-1400. 3、Long-term clinical impact and cost-effectiveness of obeticholic acid for the treatment of primary biliary cholangitis. Sumeyye Samur,Matthew Klebanoff,Reiner Banken,Daniel S. Pratt. 《Hepatology》 , 2017 , 65 (3) :920. 4、Obeticholic acid for PBC. Hugh Thomas. Nature Reviews Gastroenterology & Hepatology 13, 558-559 (2016). 5、Emerging and future therapies for nonalcoholic steatohepatitis in adults. Gesthimani Mintziori , Stergios A. Polyzos. 《Expert Opinion on Pharmacotherapy》 , 2016 , 17 (14) :1 -10. 6、9、Obeticholic acid for the treatment of primary biliary cirrhosis. Trivedi PJ, Hirschfield GM, Gershwin ME. Expert Rev Clin Pharmacol. 2016;9(1):13-26. doi:10.1586/17512433.2015.1092381. Epub 2015 Nov 7. 7、Kowdley K，Nevens F，Andreone P，et al． The first new trials for primary biliary cirrhosis in a decade: an international program evaluating the farnesoid X receptor agonist obeticholic acid［J］． Gastroenterology，2015，1481 ( 4) : S991-S992． 8、Treatment of Non-Alcoholic Fatty Liver Disease . Scherer A., Dufour J.-F. 9、Effects of obeticholic acid on lipoprotein metabolism in healthy volunteers. Pencek R, Marmon T, Roth JD, Liberman A, Hooshmand-Rad R, Young MA. Diabetes Obes Metab. 2016 Sep;18 (9):936-40. doi: 10.1111/dom.12681. Epub 2016 Jun 6. 10、Metabolite profiling of CHO?cells with different growth characteristic 11、Sun, Zhaoyun; Peng, Xinhua; Dong, Xiongzi; Shi, Wenwen - Asian Journal of Chemistry, 2012, vol. 24, # 2, p. 929 - 930 要求：下載符合需求的文獻PDF格式打包上傳   [更多]